Researchers sought to understand how communication breakdowns occur between healthcare providers and parents of children with cancer, and how these can be improved.
Clinicians should adhere to standard best practices for preventing and empirically treating secondary infections in patients hospitalized with COVID-19.
Researchers sought to determine whether conditioning chemotherapy containing alemtuzumab may improve outcomes for GVHD in pediatric patients with hematologic malignancies.
About 90% of those with familial hypercholesterolemia have not been diagnosed or treated for it, leaving them more vulnerable for COVID-19 infection and its complications.
Researchers have identified various factors associated with mortality following a diagnosis with the COVID-19 virus among recipients of allogeneic and autologous HCT.
A team of researchers sought to determine the IV tPA treatment rate of patients with minor acute ischemic stroke and compare the frequency of MRI targets by treatment stratification and clinical severity.
Researchers sought to highlight several recent advances in the epidemiology, pathogenesis, clinical features, investigation, acute management, and secondary prevention of cerebrovascular diseases in patients with hematological diseases.
Researchers worked to better understand and manage patients with mild or moderate hemophilia, who can be an underrepresented and underserved population.
Researchers determined the association between hydroxychloroquine and platelet activity, transcriptomics and vascular health in patients with systemic lupus erythematosus.
The Michigan Oncology Sequencing Program involved patients with advanced solid tumors who underwent next-generation sequencing to identify variants and potentially guide treatment.
Researchers describe the study results used to develop and validate a 4-item assessment score for predicting survival among older patients with hematologic cancers referred for chemotherapy.
Clinical Pain Advisor met with Scharles Konadu, MD, a member of the American Board of Internal Medicine Gastroenterology Specialty Board, to discuss how deeply racial inequity is woven into our health care system.
Researchers sought to determine whether there may be a link between the RhD- alloimmunization rate and RhD-positive red blood cell transfusion in trauma patients of child-bearing potential.
Although the number of reported cases of SARS-CoV-2 infection among pediatric patients with cancer has been low, the effect of the pandemic on cancer care services for this population is not well understood.
Study authors conducted a retrospective study to determine the anti-SARS-CoV-2 IgG antibody levels in convalescent plasma used to treat hospitalized patients with COVID-19.
Researchers reviewed patient samples to determine whether NGS of cell-free DNA may help in treatment decision-making for patients with hematologic malignancies who may have an infection.
Researchers have identified various factors associated with mortality following a diagnosis with the COVID-19 virus among recipients of allogeneic and autologous HCT.
The trial enrolled 511 adult participants across 47 hospital emergency departments in the United States who had at least 1 risk factor for severe COVID-19.
Researchers have sought to determine the monetary cost of specific aGVHD staging and organ involvement for patients who receive HSCT, a topic which remains poorly understood.
Ruxolitinib, a selective nonreceptor Janus kinase 1/2 inhibitor shown to have activity in adults with refractory GVHD, was studied in pediatric patients.
The trial enrolled 511 adult participants across 47 hospital emergency departments in the United States who had at least 1 risk factor for severe COVID-19.
Study authors evaluated the incidence of VTE and major bleeding in critically ill patients with COVID19, and examined the observational effect of early therapeutic anticoagulation on survival.
Study authors assessed whether convalescent plasma with high SARS-CoV-2 antibody titers would prevent progression to severe disease in older patients with COVID-19 if administered within 72 hours after the onset of mild symptoms.
Study authors assessed whether convalescent plasma with high SARS-CoV-2 antibody titers would prevent progression to severe disease in older patients with COVID-19 if administered within 72 hours after the onset of mild symptoms.
A team of investigators conducted a large retrospective, cohort study to assess whether a longitudinal link exists between H pylori infection and the risk of developing dyslipidemia.
Researchers have identified various factors associated with mortality following a diagnosis with the COVID-19 virus among recipients of allogeneic and autologous HCT.
Researchers reviewed the use of the imaging technology to mark longitudinal changes in peripapillary and macular vessel density in patients with glaucoma.
The benefits of telemedicine became more evident in the context of the elevated risk of COVID-19 infection and severe symptoms among the patients served by hematology and oncology practices.
